Novavax Inc (NVAX)

Cost of Revenue

$91.64M

TTM · Period ending: · USD

NVAX logo

NVAX Cost of Revenue

Latest reported$91.64M
NVAX TTM Cost of Revenue (-$400.00K → $91.64M)
High-resolution chart · PNG

NVAX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novavax Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
1,716,000
551,000
-594,000
-409,000
-506,000
-402,000
-400,000
-400,000
-200,000
-300,000
-300,000
-300,000
-400,000
-300,000
-300,000
-300,000
-300,000
-400,000
-400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.